PAS: Rate of Neonatal Abstinence Syndrome Increasing

This article originally appeared here.
Share this content:
PAS: Rate of Neonatal Abstinence Syndrome Increasing
PAS: Rate of Neonatal Abstinence Syndrome Increasing

TUESDAY, April 28, 2015 (HealthDay News) -- The rate of neonatal abstinence syndrome increased from 2004 to 2013, according to research published online April 26 in the New England Journal of Medicine to coincide with the annual meeting of the Pediatric Academic Societies, held from April 25 to 28 in San Diego.

Veeral N. Tolia, M.D., from the Baylor University Medical Center in Dallas, and colleagues assessed trends in incidence and health care utilization using data from infants with neonatal abstinence syndrome from 2004 through 2013 in 299 neonatal intensive care unit (NICUs).

The researchers found that 10,327 of the 674,845 infants admitted to NICUs had neonatal abstinence syndrome. The rate of NICU admissions for neonatal abstinence syndrome increased from seven to 27 cases per 1,000 admissions from 2004 through 2013; during the same period, the median length of stay increased from 13 to 19 days (both P < 0.001). There was an increase in the total percentage of NICU days nationwide that were attributed to neonatal abstinence syndrome, from 0.6 to 4.0 percent (P < 0.001). Eight centers reported that more than 20 percent of all NICU days were attributed to care for infants with neonatal abstinence syndrome in 2013.

"From 2004 through 2013, the neonatal abstinence syndrome was responsible for a substantial and growing portion of resources dedicated to critically ill neonates in NICUs nationwide," the authors write.

Two authors disclosed financial ties to the pharmaceutical industry.

Abstract
Full Text
More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

Social, Communication Delays With False-Negative on M-CHAT

Social, Communication Delays With False-Negative on M-CHAT

Delays for those who pass M-CHAT screening at 18 months but are later diagnosed with ASD

FDA Approves Aimovig to Prevent Migraines

FDA Approves Aimovig to Prevent Migraines

Patients taking Aimovig reported one to two fewer monthly migraine days than those taking pacebo

Risk of Dementia Up for Older Adults With Lowest Wealth

Risk of Dementia Up for Older Adults With ...

Increased risk seen independent of education, index of multiple deprivation, health indicators

is free, fast, and customized just for you!

Already a member?

Sign In Now »